NCT03080662

Brief Summary

The impact of the reduction of daily physical activity (DPA) in patients with COPD (chronic obstructive pulmonary disease) is a highly studied area, due to its impact on the quality of life and the clinical evolution of the disease . This fact has multifactorial components: its function is naturally diminished with time, and its effects on the loss of physical condition (decondition). However, dynamic hyperinflation and respiratory muscular dysfunction, especially in patients with more symptomatology, have been identified as those that have the most relevant factors that impact on daily physical activity Due to the detrimental effects of the pulmonary hyperinflation, the diaphragm is flatter and shorter, being in a position of mechanical disadvantage. This contributes to a reduced effort capacity and increase in the dyspnea of patients during daily activities. Resistance training improves their exercise capacity and reduces dyspnea, however it does not improve inspiratory muscle strength. It is for this reason, that specific training of the inspiratory muscles, offers special interest in patients with decreased inspiratory muscle strength and pulmonary hyperinflation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 22, 2015

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 7, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 15, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2018

Completed
Last Updated

March 15, 2017

Status Verified

March 1, 2017

Enrollment Period

2.9 years

First QC Date

March 7, 2017

Last Update Submit

March 14, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • improvement of daily physical activity

    Change From Baseline at least 10% moderate to vigorous daily physical activity measured by accelerometer

    Baseline and 5 weeks

Study Arms (2)

Sham valve (Placebo)

SHAM COMPARATOR

Sham Inspiratory valve (without resistance)

Device: ORYGEN DUAL Sham Valve

Intervention

EXPERIMENTAL

Inspiratory valve with increase resistance

Device: ORYGEN DUAL Valve

Interventions

Training of the inspiratory muscles during 5 weeks

Sham valve (Placebo)

Training of the inspiratory muscles during 5 weeks

Intervention

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be eligible for the respiratory rehabilitation programme participants must have stable COPD (at least 4 weeks), inspiratory muscle weakness (PImax \<70%) and pulmonary hyperinflation (TLC \> 120%). Patient that have signed inform consent.

You may not qualify if:

  • Hospitalization within the previous 14 days
  • Current participation in rehabilitation program,
  • Locomotor or neurological condition or disability limiting the ability to perform exercise,
  • Lung transplantation or lung volume reduction surgery foreseen within 1 month after discharge.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Del Mar

Barcelona, Barcelona, 08003, Spain

RECRUITING

Central Study Contacts

Diego Agustin Rodriguez, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 7, 2017

First Posted

March 15, 2017

Study Start

January 22, 2015

Primary Completion

December 15, 2017

Study Completion

March 15, 2018

Last Updated

March 15, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations